With the acquisition, ACM Global gains an established lab in Singapore that offers extensive clinical trials experience and knowledge of regional regulatory requirements, country specific logistics, and familiarity with customs and local languages, as well as Phoenix PCS’ new lab facility in Shanghai, China.
“This acquisition is a major milestone in our organization’s growth and represents a significant investment and commitment to the region,” said Angela J. Panzarella, president of ACM Medical Laboratory, Inc., the parent company of ACM Global Central Laboratory. “We have a long and successful history of working with partner labs in Asia, but as part of our commitment to providing robust global capabilities, operational and scientific expertise and unsurpassed service to our customers, it was important for us to establish a network of ACM Global-owned and operated labs in the Asia-Pacific region, which we see as an increasingly important region for clinical research. We are extremely pleased to be gaining the expert staff, state-of-the-art facilities and local knowledge that Phoenix PCS provides.”
“We are excited to be joining the ACM Global team,” Dr. Lee said. “My staff and I have worked very hard to create a central lab that values high quality services above all else and feel our experience, knowledge, and focus on client service fit very well with ACM and its core values. With the resources and opportunities available through ACM, we can further enhance our core services and provide even greater value to our clients, partners, and suppliers. We are looking forward to being a part of ACM’s ongoing growth and success, both in the Asia-Pacific region and globally.”